Nrx Pharmaceuticals Stock Market Value
| NRXPW Stock | USD 0.05 0 3.73% |
| Symbol | NRx |
NRx Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NRx Pharmaceuticals. If investors know NRx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NRx Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.25) | Return On Assets (1.16) | Return On Equity (6.83) |
The market value of NRx Pharmaceuticals is measured differently than its book value, which is the value of NRx that is recorded on the company's balance sheet. Investors also form their own opinion of NRx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NRx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NRx Pharmaceuticals' market value can be influenced by many factors that don't directly affect NRx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NRx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NRx Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NRx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NRx Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NRx Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NRx Pharmaceuticals.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in NRx Pharmaceuticals on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding NRx Pharmaceuticals or generate 0.0% return on investment in NRx Pharmaceuticals over 30 days. NRx Pharmaceuticals is related to or competes with NRX Pharmaceuticals, Relief Therapeutics, Quantum Si, and Reviva Pharmaceuticals. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of cen... More
NRx Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NRx Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NRx Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 19.63 | |||
| Information Ratio | 0.0622 | |||
| Maximum Drawdown | 100.2 | |||
| Value At Risk | (28.67) | |||
| Potential Upside | 27.27 |
NRx Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NRx Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NRx Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use NRx Pharmaceuticals historical prices to predict the future NRx Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0631 | |||
| Jensen Alpha | 1.23 | |||
| Total Risk Alpha | (1.41) | |||
| Sortino Ratio | 0.052 | |||
| Treynor Ratio | (1.45) |
NRx Pharmaceuticals Backtested Returns
NRx Pharmaceuticals is out of control given 3 months investment horizon. NRx Pharmaceuticals has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 16.98% are justified by taking the suggested risk. Use NRx Pharmaceuticals Mean Deviation of 11.18, risk adjusted performance of 0.0631, and Downside Deviation of 19.63 to evaluate company specific risk that cannot be diversified away. NRx Pharmaceuticals holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.79, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning NRx Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, NRx Pharmaceuticals is likely to outperform the market. Use NRx Pharmaceuticals treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to analyze future returns on NRx Pharmaceuticals.
Auto-correlation | -0.76 |
Almost perfect reverse predictability
NRx Pharmaceuticals has almost perfect reverse predictability. Overlapping area represents the amount of predictability between NRx Pharmaceuticals time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NRx Pharmaceuticals price movement. The serial correlation of -0.76 indicates that around 76.0% of current NRx Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.76 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NRx Pharmaceuticals lagged returns against current returns
Autocorrelation, which is NRx Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NRx Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of NRx Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that NRx Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NRx Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NRx Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NRx Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NRx Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
NRx Pharmaceuticals Lagged Returns
When evaluating NRx Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NRx Pharmaceuticals stock have on its future price. NRx Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NRx Pharmaceuticals autocorrelation shows the relationship between NRx Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in NRx Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.